UnknownPhase 4

Trichloroacetic Acid (TCA) Combined With Microdermabrasion in Treatment of Melasma

60 participantsStarted 2021-04-01

Plain-language summary

1. To detect the efficacy and safety of combined TCA and MDA in treating melasma. 2. To compare the efficacy and safety of using different TCA concentrations (15% \& 20%) alone and in combination with MDA in treatment of melasma.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults of 18 years and above with bilateral melasma
✓. Clinical diagnosis of melasma.
✓. Mental capacity to give informed consent.

Exclusion criteria

✕. Pregnant or nursing women
✕. Current use of hormonal birth control medication or any hormonal therapy
✕. History of laser or dermabrasion to the face within 9 months of study enrollment
✕. Patients with poor wound healing, recurrent herpes simplex and current skin infection (facial warts, molluscum contagiosum) and history of hypertropic scar/keloids
✕. Photosensitivity.
✕. Patients with unrealistic expectations All the included patients will be subjected to detailed history taking,dermatological examination and Wood's light examination to estimate the depth (epidermal, dermal or mixed) of melasma.

What they're measuring

"EFFICACY of combined Trichloroacetic acid (15% or 20 %) and microdermabrasion in treating melasma "

Timeframe: 3 months

Trial details

NCT IDNCT04823520

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-01

Contact for this trial

Hatem Ze mohamed, professor

+201003420217 zedanhzma@aun.edu.eg

View on ClinicalTrials.gov More Melasma trials